Tumor
2 competing products in clinical development for Tumor.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Eribulin mesylate + Eribulin mesylate + Rifampicin | Eisai | Phase 1 | Completed | 29 |
| Fruquintinib | HUTCHMED | Phase 1 | Completed | 23 |